Journal sections

Immunology & Immune Biomarkers | Oncology & Liquid Biopsy Biomarkers | Infectious Disease Biomarkers | Multiomics & Biomarker Discovery

 

Immunology & Immune Biomarkers

Associate Editor: Dr Stefano Cacciatore  
This section focuses on circulating biomarkers involved in immune system activity, immune regulation, and inflammatory processes. Topics include cytokines and chemokines, immune cell–derived markers, immunopathology, autoimmune disease biomarkers, and signatures associated with response to immunomodulatory therapies. Submissions may span basic, translational, and clinical research.


Oncology & Liquid Biopsy Biomarkers

Associate Editor: Prof. Roger Chammas
This section welcomes research on circulating biomarkers relevant to cancer detection, progression, prognosis, and treatment monitoring. Areas include circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, tumor‑derived proteins, liquid biopsy technologies, and biomarkers for minimal residual disease or therapy response. Both discovery‑focused and clinically oriented studies are included.


Infectious Disease Biomarkers

Associate Editor: Prof. Carla Montesano
This section covers biomarkers associated with viral, bacterial, parasitic, and fungal infections, as well as host response signatures in circulation. Topics include pathogen‑derived markers, host immunological responses, sepsis and systemic infection biomarkers, early detection methods, and biomarker‑guided patient stratification. Studies at all stages of development — from discovery to clinical validation — are welcome.


Multiomics & Biomarker Discovery

Associate Editor: Dr Nelson Soares  
This section highlights innovative analytical, technological, and computational approaches for the discovery and validation of circulating biomarkers. It includes multiomics integration (genomics, proteomics, metabolomics, transcriptomics), high‑throughput platforms, liquid biopsy technologies, assay development, biomarker validation frameworks, and AI/ML‑driven analytics. Studies may be methodological, translational, or early diagnostic in scope. Diagnostics and Therapeutics.